Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Objective: Continuation therapy with antidepressants is recommended for depressed patients who have responded to initial treatment. We quantified its efficacy in preventing relapse of depression in a meta-analysis of 54 double-blind placebo-controlled relapse prevention studies (patient n = 9268). Method: Relapse prevention studies in primary depression and depression subtypes were identified in a systematic literature search. The primary efficacy comparison was relapse rates between active and placebo arms calculated as odds ratios (ORs) using Review Manager version 5.0. Effects of patient age, drug class, diagnostic system and duration of therapy on ORs was examined, along with ORs calculated using different statistical methods. Results: Continuation antidepressants produced robust reduction in relapse (OR = 0.35; 95%CI 0.32–0.39). Pooled ORs were not affected by patient age, drug class, depression subtype or treatment duration, and were similar when calculated by different statistical methods. Patients with primary depression diagnosed by earlier diagnostic systems had slightly lower ORs than those diagnosed using DSM criteria. Conclusions: This meta-analysis emphasizes the importance of continuation treatment following acute response in depressive disorders. The robust findings of relapse prevention designs contrast with acute antidepressant efficacy studies, and may be due to enrichment of the patient population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence suggests that continuation of antidepressant treatment is effective, as it reduces risk of relapse and recurrence by 50% to 70% (Geddes 2003;Glue 2010;Kaymaz 2008)”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Glue 2010
In the citing paper
“Antidepressant medications (ADM) have proven utility not only in treating acute episodes of depression, but also in reducing the risk of relapse (Geddes et al. 2003; Kaymaz et al. 2008; Glue et al. 2010; Sim et al. 2015).”
From Predicting relapse after antidepressant withdrawal – a systematic review (2017) · cites this paper as Glue et al. 2010
In the citing paper
“Moreover, the previous pairwise meta-analyses for individuals with MDD in the maintenance phase did not evaluate the risk of individual adverse events of antidepressants [7, 10, 11].”
From Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis (2023) · cites this paper as [11]
In the citing paper
“Most trials recruited patients with depression from specialist mental health services, treated them with antidepressants for 3 to 8 months, and randomly assigned patients who had a response to therapy to continue antidepressant therapy or switch to placebo.”
From Maintenance or Discontinuation of Antidepressants in Primary Care (2021) · cites this paper as [8]
In the citing paper
“Several systematic reviews of studies have shown a higher rate of relapse among patients who discontinue antidepressant therapy than among those who continue to receive such therapy”
From Maintenance or Discontinuation of Antidepressants in Primary Care (2021) · cites this paper as [8]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
Diagnostic and Statistical Manual of Mental Disorders
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_5485 · Cited by 10,169
(1976) · Medical Entomology and Zoology · Cited by 8,899
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 5×
“Two recent meta-analyses of this area reported that the continuation treatment reduced relapse by approximately 70% compared with placebo [5,7].”
BackgroundMethodResultInfluentialAnderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Reynolds III, C. F., Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., et al. (1999) · JAMA · doi:10.1001/jama.281.1.39 · Cited by 659
Prien, R. F. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220086014 · Cited by 565
Executive Dysfunction and Long-term Outcomes of Geriatric Depression
Alexopoulos, G. S., Meyers, B. S., Young, R. C., Kalayam, B., Kakuma, T., Gabrielle, M., Sirey, J. A., & Hull, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.285 · Cited by 486
Charney, D. S., Reynolds, C. F., Lewis, L., Lebowitz, B. D., Sunderland, T., Alexopoulos, G. S., Blazer, D. G., Katz, I. R., Meyers, B. S., Arean, P. A., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.664 · Cited by 462
Melfi, C. A., Chawla, A. J., Croghan, T. W., Hanna, M. P., Kennedy, S., & Sredl, K. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1128 · Cited by 409
Sertraline in the Prevention of Depression
Doogan, D. P., & Caillard, V. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.217 · Cited by 245
The Prophylactic Efficacy of Fluoxetine in Unipolar Depression
Montgomery, S. A., Dufour, H., Brion, S., Gailledreau, J., Laqueille, X., Ferrey, G., Moron, P., Parant-Lucena, N., Singer, L., Danion, J. M., et al. (1988) · British Journal of Psychiatry · doi:10.1192/s0007125000297328 · Cited by 232
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090053011 · Cited by 212
Reimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., Beasley, Jr., Michelson, D., Roback, P., & Sundell, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1247 · Cited by 204
Lustman, P. J., Clouse, R. E., Nix, B. D., Freedland, K. E., Rubin, E. H., McGill, J. B., Williams, M. M., Gelenberg, A. J., Ciechanowski, P. S., & Hirsch, I. B. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.521 · Cited by 202
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents
Emslie, G. J., Kennard, B. D., Mayes, T. L., Nightingale-Teresi, J., Carmody, T., Hughes, C. W., Rush, A. J., Tao, R., & Rintelmann, J. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091453 · Cited by 188
Keller, M. B. (1998) · JAMA · doi:10.1001/jama.280.19.1665 · Cited by 184
Montgomery, S. A., Rasmussen, J. G. C., & Tanghøj, P. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00008 · Cited by 163
Khan, A., Khan, S. R., Walens, G., Kolts, R., & Giller, E. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300059 · Cited by 158
(1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810090025004 · Cited by 157
Old Age Depression Interest Group, Jacoby, R., Lunn, A. D., Ardern, M., Bergmann, K., Conway, J., Cooling, N., Davies, G., Fisk, J., Gehlhaar, E., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.2.175 · Cited by 155
Glen, A. I. M., Johnson, A. L., & Shepherd, M. (1984) · Psychological Medicine · doi:10.1017/s0033291700003068 · Cited by 141
Kaymaz, N., van Os, J., Loonen, A. J. M., & Nolan, W. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0910 · Cited by 135
Escitalopram continuation treatment prevents relapse of depressive episodes
Rapaport, M. H., Bose, A., & Zheng, H. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0107 · Cited by 121
Maintenance Therapy for Chronic Depression: A Controlled Clinical Trial of Desipramine
Kocsis, J. H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830090013002 · Cited by 121
Keller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dunner, D. L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0812 · Cited by 116
Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression
McGrath, P. J., Stewart, J. W., Quitkin, F. M., Chen, Y., Alpert, J. E., Nierenberg, A. A., Fava, M., Cheng, J., & Petkova, E. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1542 · Cited by 111
Klysner, R., Bent-Hansen, J., Hansen, H. L., Lunde, M., Pleidrup, E., Poulsen, D. L., Andersen, M., & Petersen, H. E. H. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.1.29 · Cited by 106
Continuation Therapy with Amitriptyline in Depression
Coppen, A., Ghose, K., Montgomery, S., Rama Rao, V. A., Bailey, J., & Jorgensen, A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.1.28 · Cited by 103
Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder
Gorwood, P. A. P. M., Weiller, E., Lemming, O. M., & Katona, C. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000240823.94522.4c · Cited by 94
Perahia, D. G., Gilaberte, I., Wang, F., Wiltse, C. G., Huckins, S. A., Clemens, J. W., Montgomery, S. A., Montejo, A. L., & Detke, M. J. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.346 · Cited by 94
Versiani, M., Mehilane, L., Gaszner, P., Arnaud-Castiglioni, R., & The Metrifonate Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0610 · Cited by 88
Thase, M. E., Nierenberg, A. A., Keller, M. B., & John Panagides for the Relapse Prevention Study Group (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1006 · Cited by 85
Robert, P., Montgomery, S. A., Darcourt, G., Robert, G., Houillon, P., Bouchard, J. M., Tatossian, A., Planche, R., Bourgeois, M., Richou, H., et al. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199503001-00006 · Cited by 85
Hochstrasser, B., Isaksen, P. M., Koponen, H., Lauritzen, L., Mahnert, F. A., Rouillon, F., Wade, A. G., Andersen, M., Pedersen, S. F., De Swart, J. C. G., et al. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.4.304 · Cited by 85
[Recurrence of unipolar depression and efficacy of maprotiline].
Rouillon, F., Phillips, R., Serrurier, D., Ansart, E., & Mj, G. (1989) · PubMed · Cited by 81
Robinson, D. S., Sc, L., Bennett, B., Laux, D. E., Devereaux, E., Kayser, A., CORCELLA, J., & ALBRIGHT, D. (1991) · PubMed · Cited by 79
Kocsis, J. H., Schatzberg, A., Rush, A. J., Klein, D. N., Howland, R., Gniwesch, L., Davis, S. M., & Harrison, W. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.8.723 · Cited by 77
Gelenberg, A. J., Trivedi, M. H., Rush, A. J., Thase, M. E., Howland, R., Klein, D. N., Kornstein, S. G., Dunner, D. L., Markowitz, J. C., Hirschfeld, R. M. A., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01971-6 · Cited by 76
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.31 · Cited by 75
Feiger, A. D., Bielski, R. J., Bremner, J., Heiser, J. F., Trivedi, M., Wilcox, C. S., Roberts, D. L., Kensler, T. T., McQuade, R. D., Kaplita, S. B., et al. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199901000-00002 · Cited by 74
Wilson, K. C. M., Mottram, P. G., Ashworth, L., & Abou-Saleh, M. T. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.6.492 · Cited by 74
Cipriani, A., Geddes, J. R., Furukawa, T. A., & Barbui, C. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200903 · Cited by 73
Phenelzine for chronic depression: a study of continuation treatment.
Harrison, W. M., Rabkin, J. G., Stewart, J. W., McGrath, P. J., TRICAMO, E., & Quitkin, F. M. (1986) · PubMed · Cited by 72
Gepirone in the Treatment of Major Depression
JENKINS, S. W., ROBINSON, D. S., FABRE, L. F., ANDARY, J. J., MESSINA, M. E., & REICH, L. A. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199006001-00014 · Cited by 71
Venlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression
Montgomery, S. A., Entsuah, R., Hackett, D., Kunz, N. R., Rudolph, R. L., & Venlafaxine 335 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0307 · Cited by 69
Extended-release venlafaxine in relapse prevention for patients with major depressive disorder
Simon, J. S., Aguiar, L. M., Kunz, N. R., & Lei, D. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.10.004 · Cited by 69
Schmidt, M. E., Fava, M., Robinson, J. M., & Judge, R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1107 · Cited by 68
Terra, J.-L., & Montgomery, S. (1998) · PubMed · Cited by 66
Weihs, K. L., Houser, T. L., Batey, S. R., Ascher, J. A., Bolden-Watson, C., Donahue, R. M. J., & Metz, A. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01317-8 · Cited by 65
Recurrence of depression after discontinuation of long-term amitriptyline treatment
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.3.325 · Cited by 62
Kornstein, S. G., Bose, A., Li, D., Saikali, K. G., & Gandhi, C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1115 · Cited by 60
Fluoxetine in the Prevention of Depressive Recurrences: A Double-Blind Study
Gilaberte, I., Montejo, A. L., de la Gandara, J., Perez-Sola, V., Bernardo, M., Massana, J., Martin-Santos, R., Santiso, A., Noguera, R., Casais, L., et al. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00009 · Cited by 58
Terra, J. L., & Montgomery, S. A. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199803000-00001 · Cited by 51
Unipolar depression in the elderly
Cook, B. L., Helms, P. M., Smith, R. E., & Tsai, M. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90031-5 · Cited by 36
Prevention of recurrent depressive episodes with milnacipran: consequences on quality of life
Rouillon, F., Berdeaux, G., Bisserbe, J. C., Warner, B., Mesbah, M., Smadja, C., & Chwalow, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00109-3 · Cited by 36
Use of Phenelzine in Continuation Therapy
Davidson, J., & Raft, D. (1984) · Neuropsychobiology · doi:10.1159/000118076 · Cited by 33
Relapse Prevention With Gepirone ER in Outpatients With Major Depression
Keller, M. B., Ruwe, F. J. L., Janssens, C. J. J. G., Sitsen, J. M. A., Jokinen, R., & Janczewski, J. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150221.53877.d9 · Cited by 32
Kamijima, K., Burt, T., Cohen, G., Arano, I., & Hamasaki, T. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000182118.57510.d1 · Cited by 31
Burke, W. J., Hendricks, S. E., McArthur-Miller, D., Jacques, D., Bessette, D., McKillip, T., Stull, T., & Wilson, J. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00006 · Cited by 30
Amsterdam, J. D., Brunswick, D. J., & Gibertini, M. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.10.005 · Cited by 12
Prophylactic effect of mianserin on recurrent depression
Kishimoto, A., Mizukawa, R., Matsuzaki, F., Hazama, H., Kamase, H., Tanaka, K., & Kunimoto, N. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01484.x · Cited by 11
Efficacy of amineptine in the prevention of relapse in unipolar depression
Ferreri, M., Colonna, L., & Leger, J.-M. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199707003-00007 · Cited by 10
Research works printed but not linked: 5
- Rouillon F, 1989, Encephale, 15, 527
- Lendresse PH, 1985, Psychiatrie Francaise, 16, 156
- Robinson DS, 1991, Psychopharmacol Bull, 27, 31
- Harrison W, 1986, J Clin Psychiatry, 47, 346
- American Psychiatric Association, 1980, Diagnostic and statistical manual of mental disorders
Cited by
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Huhn, M., Tardy, M., Spineli, L. M., Kissling, W., Förstl, H., Pitschel-Walz, G., Leucht, C., Samara, M., Dold, M., Davis, J. M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.112 · Cited by 333
Bockting, C. L., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.02.003 · Cited by 295
“35 (Geddes et al., 2003; Glue et al., 2010; Hansen et al., 2008; Kaymaz et al., 2008).”
BackgroundThe neurobiology of depression
Palazidou, E. (2012) · British Medical Bulletin · doi:10.1093/bmb/lds004 · Cited by 288
ACOG Committee on Clinical Practice Guidelines–Obstetrics (2023) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000005202 · Cited by 252
Metadata
- Authors
- Glue, P., Donovan, M. R., Kolluri, S., & Emir, B.
- Affiliations
- University of Otago (NZ)
- The Graduate Center, CUNY (US)
- Pfizer (United States) (US)
- Corresponding author
- Glue, Paul
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2010-08
- Volume
- 44
- Issue
- 8
- Pages
- 697-705
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2049226284
- Semantic Scholar
- e4afa6b21c4ea03023250b2b6602396575035da1
- Cited by
- 100
- References
- 71
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 8 · 2019: 10 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 2 · 2012: 7
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- relapse prevention, depression, relapse rate, antidepressants, primary depression, depression subtypes, diagnostic systems, DSM diagnostic criteria, treatment duration, patient age, comparison of statistical methods
- MeSH terms
- Clinical Trials as Topic, Depressive Disorder, Humans, Odds Ratio, Treatment Outcome, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.